Researchers from the University of Otago—Ōtākou Whakaihu Waka have created a world-first epigenetic tool that has ...

Market uncertainty makes investors nervous about investing in speculative industries. But Wall Street has high hopes for ...

Data highlights PYLARIFY’s ability to detect recurrent prostate cancer in patients with low PSAReal-world evidence of PYLARIFY’s effectiveness in ...

Key Takeaways Spironolactone is effective for both premenopausal and postmenopausal women Finasteride is primarily used for ...

Androgen insensitivity is an umbrella term for a number of genetic conditions where the body does not respond appropriately to testosterone and other androgens. There are multiple causes of androgen ...

To do this, they developed the "Androgen Clock," an analysis platform which examines specific DNA regions that change over time in the presence of androgens. While researchers have not yet been able ...

It has been revealed through a wider probe into systemic doping within Russian sports by the International Testing Agency ...

Researchers from the University of Otago – Ōtākou Whakaihu Waka have created a world-first epigenetic tool which has ...

In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.

"RedHill Biopharma launches trial of combination therapy for prostate cancer" was originally created and published by ...

Adrenal insufficiency or bilateral oophorectomy (surgical menopause) result in severe androgen deficiency, which can be clinically associated with impaired libido, drive and energy. Physiological ...

Researchers from the University of Otago – Ōtākou Whakaihu Waka have created a world-first epigenetic tool which has ...